<DOC>
	<DOCNO>NCT01742429</DOCNO>
	<brief_summary>To test efﬁcacy 14 day levoﬂoxacin bismuth-containing second-line therapy resistant Helicobacter pylorus infection , compare classical quadruple therapy .</brief_summary>
	<brief_title>Levoﬂoxacin Bismuth-containing Therapy Versus Quadruple Therapy Second-line Treatment Resistant Helicobacter Pylori Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Bismuth subsalicylate</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>patient fail H.pylori therapy include clarithromycin , metronidazole and/or amoxicillin ( allergic ) . patient le 18 year old , previous gastric surgery , pregnancy , lactation , major systemic disease , administration antibiotic , bismuth , antisecretory drug precede 8 week , allergy one medication use quadruple regimen .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>second line treatment</keyword>
</DOC>